Afatinib in combination with GEMOX chemotherapy as the adjuvant treatment in patients with ErbB pathway mutated, resectable gallbladder cancer: study protocol for a ctDNA-based, multicentre, open-label, randomised, controlled, phase II trial
Sign Up to like & getrecommendations! Published in 2023 at "BMJ Open"
DOI: 10.1136/bmjopen-2022-061892
Abstract: Introduction Gallbladder cancer (GBC) is an aggressive type of digestive system cancer with a dismal outcome. Given the lack of effective treatment options, the disease rapidly reoccurs and 5-year survival rate is read more here.
Keywords: cancer; afatinib; treatment; medicine ... See more keywords
Astraglaus polysaccharide protects diabetic cardiomyopathy by activating NRG1/ErbB pathway.
Sign Up to like & getrecommendations! Published in 2018 at "Bioscience trends"
DOI: 10.5582/bst.2018.01027
Abstract: Diabetic cardiomyopathy (DCM) is one of the main cardiac complications among diabetic patients. According to previous studies, the pathogenesis of DCM is associated with oxidative stress, apoptosis and proliferation of local cardiac cells. It showed,… read more here.
Keywords: nrg1 erbb; dcm; erbb pathway; astraglaus polysaccharide ... See more keywords